Charles Kenneth Meshul - Publications

Affiliations: 
Behavioral Neuroscience Oregon Health and Science University, Portland, OR 
Area:
Glutamate, Basal Ganglia, Parkinson's Disease, Exercise, Drug Abuse
Website:
http://www.ohsu.edu/xd/education/schools/school-of-medicine/academic-programs/graduate-studies/faculty/grad-studies-faculty.cfm?facultyid=249

105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Xu M, Bohlen JK, Moore C, Nipper MA, Finn DA, Jones CE, Lim MM, Meshul CK. Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism. Journal of Neuroscience Research. PMID 31535395 DOI: 10.1002/jnr.24520  0.32
2019 Churchill MJ, Cantu MA, Kasanga EA, Moore C, Salvatore MF, Meshul CK. Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson's disease. Neuroscience. PMID 31220543 DOI: 10.1016/j.neuroscience.2019.06.006  0.32
2018 Shimamoto A, Rappeneau V, Munjal H, Farris T, Davis C, Wilson A, Edwards M, Moore C, Reynolds C, Meshul CK. Glutamate-glutamine transfer and chronic stress-induced sex differences in cocaine responses. Neuroscience. PMID 30240589 DOI: 10.1016/j.neuroscience.2018.09.009  0.32
2018 Elliott JE, De Luche SE, Churchill MJ, Moore C, Cohen AS, Meshul CK, Lim MM. Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice. Sleep. PMID 29315422 DOI: 10.1093/sleep/zsx212  0.32
2017 Reidling JC, Relaño-Ginés A, Holley SM, Ochaba J, Moore C, Fury B, Lau A, Tran AH, Yeung S, Salamati D, Zhu C, Hatami A, Cepeda C, Barry JA, Kamdjou T, ... ... Meshul CK, et al. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports. PMID 29233555 DOI: 10.1016/j.stemcr.2017.11.005  0.32
2017 Parievsky A, Moore C, Kamdjou T, Cepeda C, Meshul CK, Levine MS. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 108: 29-44. PMID 28757327 DOI: 10.1016/j.nbd.2017.07.020  0.32
2017 Bentea E, Moore C, Deneyer L, Verbruggen L, Churchill MJ, Hood RL, Meshul CK, Massie A. Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease. Brain Research Bulletin. PMID 28232022 DOI: 10.1016/j.brainresbull.2017.02.005  0.32
2016 Hood RL, Liguore WA, Moore C, Pflibsen L, Meshul CK. Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice. Brain Research. PMID 27350080 DOI: 10.1016/j.brainres.2016.06.032  0.32
2015 Tamburrino A, Churchill MJ, Wan OW, Colino-Sanguino Y, Ippolito R, Bergstrand S, Wolf DA, Herz NJ, Sconce MD, Björklund A, Meshul CK, Decressac M. Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease. Acta Neuropathologica Communications. 3: 84. PMID 26666562 DOI: 10.1186/s40478-015-0263-6  1
2015 Pflibsen L, Stang KA, Sconce MD, Wilson VB, Hood RL, Meshul CK, Mitchell SH. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Journal of Neuroscience Research. 93: 1849-64. PMID 26332770 DOI: 10.1002/jnr.23638  1
2015 Jimenez VA, Helms CM, Cornea A, Meshul CK, Grant KA. An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques. Frontiers in Cellular Neuroscience. 9: 260. PMID 26236193 DOI: 10.3389/fncel.2015.00260  0.48
2015 Wang P, Eshaq RS, Meshul CK, Moore C, Hood RL, Leidenheimer NJ. Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA. Frontiers in Cellular Neuroscience. 9: 188. PMID 26041994 DOI: 10.3389/fncel.2015.00188  1
2015 Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK. Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice. Plos One. 10: e0128510. PMID 26035833 DOI: 10.1371/journal.pone.0128510  1
2015 Sconce MD, Churchill MJ, Greene RE, Meshul CK. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease. Neuroscience. 299: 156-74. PMID 25943481 DOI: 10.1016/j.neuroscience.2015.04.069  1
2015 Bentea E, Sconce MD, Churchill MJ, Van Liefferinge J, Sato H, Meshul CK, Massie A. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT. Neuroscience Letters. 593: 1-6. PMID 25766755 DOI: 10.1016/j.neulet.2015.03.013  1
2015 Sconce MD, Churchill MJ, Moore C, Meshul CK. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease. Neuroscience. 290: 454-71. PMID 25655214 DOI: 10.1016/j.neuroscience.2014.12.080  1
2015 Jimenez VA, Helms CM, Cornea A, Meshul CK, Grant KA. An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques Frontiers in Cellular Neuroscience. 9. DOI: 10.3389/fncel.2015.00260  1
2014 Spinelli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E, Moore C, Meshul CK, Unni VK. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 2037-50. PMID 24501346 DOI: 10.1523/JNEUROSCI.2581-13.2014  1
2013 Baptista MA, Dave KD, Frasier MA, Sherer TB, Greeley M, Beck MJ, Varsho JS, Parker GA, Moore C, Churchill MJ, Meshul CK, Fiske BK. Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs. Plos One. 8: e80705. PMID 24244710 DOI: 10.1371/journal.pone.0080705  1
2013 Mao P, Meshul CK, Thuillier P, Reddy PH. Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's Disease. Pharmaceuticals (Basel, Switzerland). 6: 108-23. PMID 23543038 DOI: 10.3390/ph6010108  1
2013 Mercer AJ, Hentges ST, Meshul CK, Low MJ. Unraveling the central proopiomelanocortin neural circuits. Frontiers in Neuroscience. 7: 19. PMID 23440036 DOI: 10.3389/fnins.2013.00019  1
2012 Alix JJ, Zammit C, Riddle A, Meshul CK, Back SA, Valentino M, Fern R. Central axons preparing to myelinate are highly sensitive [corrected] to ischemic injury. Annals of Neurology. 72: 936-51. PMID 23280842 DOI: 10.1002/ana.23690  1
2012 Paquette MA, Martinez AA, Macheda T, Meshul CK, Johnson SW, Berger SP, Giuffrida A. Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors. The European Journal of Neuroscience. 36: 3224-34. PMID 22861201 DOI: 10.1111/j.1460-9568.2012.08243.x  1
2012 Munhall AC, Wu YN, Belknap JK, Meshul CK, Johnson SW. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons. Neurotoxicology. 33: 429-35. PMID 22521663 DOI: 10.1016/j.neuro.2012.04.006  1
2012 Walker RH, Moore C, Davies G, Dirling LB, Koch RJ, Meshul CK. Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. Plos One. 7: e32919. PMID 22427909 DOI: 10.1371/journal.pone.0032919  1
2012 Mao P, Meshul CK, Thuillier P, Goldberg NR, Reddy PH. CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria. Plos One. 7: e29343. PMID 22235287 DOI: 10.1371/journal.pone.0029343  1
2012 Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiology of Disease. 45: 1051-67. PMID 22198503 DOI: 10.1016/j.nbd.2011.12.024  1
2011 Collins LL, Lee YF, Ting HJ, Lin WJ, Liu NC, Meshul CK, Uno H, Bao BY, Chen YT, Chang C. The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice. Reproductive Biology and Endocrinology : Rb&E. 9: 138. PMID 21995792 DOI: 10.1186/1477-7827-9-138  1
2011 Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. Journal of Neuroscience Research. 89: 1698-706. PMID 21748776 DOI: 10.1002/jnr.22699  1
2011 Darvesh AS, Carroll RT, Geldenhuys WJ, Gudelsky GA, Klein J, Meshul CK, Van der Schyf CJ. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opinion On Drug Discovery. 6: 109-127. PMID 21532928 DOI: 10.1517/17460441.2011.547189  1
2011 Goldberg NR, Meshul CK. Effect of intermittent washout periods on progressive lesioning of the nigrostriatal pathway with 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience. 182: 203-7. PMID 21402128 DOI: 10.1016/j.neuroscience.2011.03.015  1
2011 Goldberg NR, Haack AK, Lim NS, Janson OK, Meshul CK. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 180: 256-71. PMID 21335067 DOI: 10.1016/j.neuroscience.2011.02.027  1
2011 Smith BA, Goldberg NR, Meshul CK. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse. Brain Research. 1386: 70-80. PMID 21315689 DOI: 10.1016/j.brainres.2011.02.003  1
2011 Goldberg NR, Haack AK, Meshul CK. Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease. Neuroscience. 172: 443-52. PMID 20933577 DOI: 10.1016/j.neuroscience.2010.09.062  1
2011 Schang AY, Fisher BE, Sashkin NR, Moore C, Dirling LB, Petzinger GM, Jakowec MW, Meshul CK. Correlates and analysis of motor function in humans and animal models of parkinson's disease Neuromethods. 50: 55-90. DOI: 10.1007/978-1-60761-883-6_3  1
2011 Petzinger GM, Fisher BE, Meshul CK, Walsh JP, Akopian G, Jakowec MW. Effects of Exercise on Basal Ganglia Function in Parkinson's Disease and its Animal Models Parkinson's Disease: Non-Motor and Non-Dopaminergic Features. 416-431. DOI: 10.1002/9781444397970.ch37  1
2010 Massie A, Goursaud S, Schallier A, Vermoesen K, Meshul CK, Hermans E, Michotte Y. Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochemistry International. 57: 572-8. PMID 20643175 DOI: 10.1016/j.neuint.2010.07.004  1
2010 Walker RH, Davies G, Koch RJ, Haack AK, Moore C, Meshul CK. Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6-hydroxydopamine-lesioned rats. Journal of Neuroscience Research. 88: 2964-75. PMID 20544826 DOI: 10.1002/jnr.22446  1
2010 Petzinger GM, Fisher BE, Van Leeuwen JE, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S141-5. PMID 20187247 DOI: 10.1002/mds.22782  1
2010 McKee BL, Keyghobadi M, Tozier De La Poterie AP, Meshul CK. Lesion of the ventromedial nucleus of the thalamus blocks acute cocaine-induced changes in striatal glutamate. Synapse (New York, N.Y.). 64: 445-8. PMID 20169577 DOI: 10.1002/syn.20749  1
2010 Paquette MA, Anderson AM, Lewis JR, Meshul CK, Johnson SW, Paul Berger S. MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. Neuropharmacology. 58: 1002-8. PMID 20079362 DOI: 10.1016/j.neuropharm.2010.01.003  1
2009 Meredith GE, Totterdell S, Beales M, Meshul CK. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Experimental Neurology. 219: 334-40. PMID 19523952 DOI: 10.1016/j.expneurol.2009.06.005  1
2009 Fu Y, Tian W, Pratt EB, Dirling LB, Shyng SL, Meshul CK, Cohen DM. Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion. Plos One. 4: e5679. PMID 19479076 DOI: 10.1371/journal.pone.0005679  1
2009 Walker RH, Koch RJ, Sweeney JE, Moore C, Meshul CK. Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum. Neuroreport. 20: 770-5. PMID 19373115 DOI: 10.1097/WNR.0b013e32832ad556  1
2009 Paquette MA, Foley K, Brudney EG, Meshul CK, Johnson SW, Berger SP. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism. Psychopharmacology. 204: 743-54. PMID 19283364 DOI: 10.1007/s00213-009-1505-8  1
2009 Meyer PJ, Meshul CK, Phillips TJ. Ethanol- and cocaine-induced locomotion are genetically related to increases in accumbal dopamine. Genes, Brain, and Behavior. 8: 346-55. PMID 19220481 DOI: 10.1111/j.1601-183X.2009.00481.x  1
2009 Walker RH, Koch RJ, Moore C, Meshul CK. Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism. Synapse (New York, N.Y.). 63: 136-46. PMID 19021215 DOI: 10.1002/syn.20592  1
2008 Paquette MA, Brudney EG, Putterman DB, Meshul CK, Johnson SW, Berger SP. Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias. Neuroreport. 19: 111-5. PMID 18281903 DOI: 10.1097/WNR.0b013e3282f3b0d1  1
2007 Gunzler SA, Shakil S, Carlson NE, Nutt JG, Meshul CK. Low doses of apomorphine transiently reduce locomotor activity in MPTP-treated mice. Neuroscience Letters. 428: 64-7. PMID 17964074 DOI: 10.1016/j.neulet.2007.09.049  1
2007 Chen YT, Collins LL, Uno H, Chou SM, Meshul CK, Chang SS, Chang C. Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor. Brain Research. 1168: 72-82. PMID 17706948 DOI: 10.1016/j.brainres.2007.06.069  1
2007 Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 334-47. PMID 16757980 DOI: 10.1038/sj.jcbfm.9600344  1
2005 Holmer HK, Keyghobadi M, Moore C, Meshul CK. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 136: 333-41. PMID 16198485 DOI: 10.1016/j.neuroscience.2005.08.003  1
2005 Hughes-Davis EJ, Cogen JP, Jakowec MW, Cheng HW, Grenningloh G, Meshul CK, McNeill TH. Differential regulation of the growth-associated proteins GAP-43 and superior cervical ganglion 10 in response to lesions of the cortex and substantia nigra in the adult rat. Neuroscience. 135: 1231-9. PMID 16165289 DOI: 10.1016/j.neuroscience.2005.07.017  1
2005 Shakil SS, Holmer HK, Moore C, Abernathy AT, Jakowec MW, Petzinger GM, Meshul CK. High and low responders to novelty show differential effects in striatal glutamate. Synapse (New York, N.Y.). 58: 200-7. PMID 16138315 DOI: 10.1002/syn.20198  1
2005 Sirvanci S, Meshul CK, Onat F, San T. Glutamate and GABA immunocytochemical electron microscopy in the hippocampal dentate gyrus of normal and genetic absence epilepsy rats. Brain Research. 1053: 108-15. PMID 16038886 DOI: 10.1016/j.brainres.2005.06.024  1
2005 Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse (New York, N.Y.). 57: 100-12. PMID 15906381 DOI: 10.1002/syn.20163  1
2005 McKee BL, Meshul CK. Time-dependent changes in extracellular glutamate in the rat dorsolateral striatum following a single cocaine injection. Neuroscience. 133: 605-13. PMID 15878803 DOI: 10.1016/j.neuroscience.2005.02.020  1
2005 Touchon JC, Holmer HK, Moore C, McKee BL, Frederickson J, Meshul CK. Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine. Experimental Neurology. 193: 131-40. PMID 15817272 DOI: 10.1016/j.expneurol.2004.11.023  1
2004 Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK. Dopamine modulates release from corticostriatal terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9541-52. PMID 15509741 DOI: 10.1523/JNEUROSCI.2891-04.2004  1
2004 Collins LL, Lee YF, Heinlein CA, Liu NC, Chen YT, Shyr CR, Meshul CK, Uno H, Platt KA, Chang C. Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. Proceedings of the National Academy of Sciences of the United States of America. 101: 15058-63. PMID 15477591 DOI: 10.1073/pnas.0405700101  1
2004 Dervan AG, Meshul CK, Beales M, McBean GJ, Moore C, Totterdell S, Snyder AK, Meredith GE. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Experimental Neurology. 190: 145-56. PMID 15473988 DOI: 10.1016/j.expneurol.2004.07.004  1
2004 Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. Journal of Neuroscience Research. 77: 378-90. PMID 15248294 DOI: 10.1002/jnr.20162  1
2004 Touchon JC, Moore C, Frederickson J, Meshul CK. Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations. Synapse (New York, N.Y.). 51: 287-98. PMID 14696016 DOI: 10.1002/syn.10306  1
2004 Kozell LB, Meshul CK. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse (New York, N.Y.). 51: 224-32. PMID 14696010 DOI: 10.1002/syn.10304  1
2003 McNeill TH, Brown SA, Hogg E, Cheng HW, Meshul CK. Synapse replacement in the striatum of the adult rat following unilateral cortex ablation. The Journal of Comparative Neurology. 467: 32-43. PMID 14574678 DOI: 10.1002/cne.10907  1
2003 Sirvanci S, Meshul CK, Onat F, San T. Immunocytochemical analysis of glutamate and GABA in hippocampus of genetic absence epilepsy rats (GAERS). Brain Research. 988: 180-8. PMID 14519540 DOI: 10.1016/S0006-8993(03)03349-3  1
2003 Robinson S, Freeman P, Moore C, Touchon JC, Krentz L, Meshul CK. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Experimental Neurology. 180: 74-87. PMID 12668150 DOI: 10.1016/S0014-4886(02)00050-X  1
2003 Kozell LB, Meshul CK. Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine Psychopharmacology. 165: 337-345. PMID 12459930  1
2003 Şirvanci S, Midillioǧlu Ş, Meshul CK, Onat F, Şan T. Dendritic spines in the hippocampus of Genetic Absence Epilepsy Rats (GAERS): An ultrastructural quantitative analysis Marmara Medical Journal. 16: 195-200.  1
2003 Jakowec MW, Fisher B, Nixon K, Hogg E, Meshul C, Bremmer S, McNeill T, Petzinger GM. Neuroplasticity in the MPTP-lesioned mouse and nonhuman primate Annals of the New York Academy of Sciences. 991: 298-301.  1
2002 See RE, Berglind WJ, Krentz L, Meshul CK. Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of gamma-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats. Journal of Neurochemistry. 82: 172-80. PMID 12091478 DOI: 10.1046/j.1471-4159.2002.00974.x  1
2002 Meshul CK, Kamel D, Moore C, Kay TS, Krentz L. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. Experimental Neurology. 175: 257-74. PMID 12009777 DOI: 10.1006/exnr.2002.7900  1
2001 Robinson S, Krentz L, Moore C, Meshul CK. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats. Synapse (New York, N.Y.). 42: 54-61. PMID 11668591 DOI: 10.1002/syn.1099  1
2001 Kozell LB, Meshul CK. The effects of acute or repeated cocaine administration on nerve terminal glutamate within the rat mesolimbic system. Neuroscience. 106: 15-25. PMID 11564413 DOI: 10.1016/S0306-4522(01)00274-3  1
2001 Andreassen OA, Meshul CK, Moore C, Jørgensen HA. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration. Psychopharmacology. 157: 11-9. PMID 11512038 DOI: 10.1007/s002130100767  0.32
2001 Rubinstein M, Cepeda C, Hurst RS, Flores-Hernandez J, Ariano MA, Falzone TL, Kozell LB, Meshul CK, Bunzow JR, Low MJ, Levine MS, Grandy DK. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3756-63. PMID 11356863  1
2000 Meshul CK, Cogen JP, Cheng HW, Moore C, Krentz L, McNeill TH. Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway. Experimental Neurology. 165: 191-206. PMID 10964498 DOI: 10.1006/exnr.2000.7467  1
2000 Meshul CK, Allen C. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion. Synapse (New York, N.Y.). 36: 129-42. PMID 10767060 DOI: 10.1002/(SICI)1098-2396(200005)36:2<129::AID-SYN6>3.0.CO;2-4  1
1999 Buckman JF, Meshul CK. Glial differences between naïve withdrawal seizure-prone and -resistant mice. Alcoholism, Clinical and Experimental Research. 23: 1905-13. PMID 10630609  1
1999 Buckman JF, Meshul CK, Finn DA, Janowsky A. Glutamate uptake in mice bred for ethanol withdrawal severity. Psychopharmacology. 143: 174-82. PMID 10326780 DOI: 10.1007/s002130050933  1
1999 Burrows KB, Meshul CK. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. Neuroscience. 90: 833-50. PMID 10218784 DOI: 10.1016/S0306-4522(98)00506-5  1
1999 Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience. 88: 1-16. PMID 10051185 DOI: 10.1016/S0306-4522(98)00189-4  1
1998 Keys AS, Mark GP, Emre N, Meshul CK. Reduced glutamate immunolabeling in the nucleus accumbens following extended withdrawal from self-administered cocaine. Synapse (New York, N.Y.). 30: 393-401. PMID 9826231 DOI: 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H  1
1998 Meshul CK, Noguchi K, Emre N, Ellison G. Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens. Synapse (New York, N.Y.). 30: 211-20. PMID 9723791 DOI: 10.1002/(SICI)1098-2396(199810)30:2<211::AID-SYN11>3.0.CO;2-4  1
1997 Kennedy M, Kim KH, Harten B, Brown J, Planck S, Meshul C, Edelhauser H, Rosenbaum JT, Armstrong CA, Ansel JC. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells Investigative Ophthalmology and Visual Science. 38: 2483-2491. PMID 9375566  1
1997 Burrows KB, Meshul CK. Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex. Synapse (New York, N.Y.). 27: 133-44. PMID 9266774 DOI: 10.1002/(SICI)1098-2396(199710)27:2<133::AID-SYN4>3.0.CO;2-F  1
1997 Buckman JF, Meshul CK. Immunocytochemical analysis of glutamate and GABA in selectively bred mice. Brain Research. 760: 193-203. PMID 9237535 DOI: 10.1016/S0006-8993(97)00281-3  1
1997 Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Experimental Eye Research. 64: 85-96. PMID 9093024 DOI: 10.1006/exer.1996.0184  1
1996 Meshul CK, Buckman JF, Allen C, Riggan JP, Feller DJ. Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse (New York, N.Y.). 22: 350-61. PMID 8867029 DOI: 10.1002/(SICI)1098-2396(199604)22:4<350::AID-SYN6>3.0.CO;2-A  1
1996 Meshul CK, Bunker GL, Mason JN, Allen C, Janowsky A. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. Journal of Neurochemistry. 67: 1965-73. PMID 8863502  1
1996 Williams TE, Meshul CK, Cherry NJ, Tiffany NM, Eckenstein FP, Woodward WR. Characterization and distribution of basic fibroblast growth factor-containing cells in the rat hippocampus. The Journal of Comparative Neurology. 370: 147-58. PMID 8808727 DOI: 10.1002/(SICI)1096-9861(19960624)370:2<147::AID-CNE2>3.0.CO;2-2  1
1994 Urbanski HF, Fahy MM, Daschel M, Meshul C. N-Methyl-D-aspartate receptor gene expression in the hamster hypothalamus and in immortalized luteinizing hormone-releasing hormone neurones Journal of Reproduction and Fertility. 100: 5-9. PMID 8182610  1
1994 Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Research. 648: 181-95. PMID 7922533 DOI: 10.1016/0006-8993(94)91117-7  1
1994 Meshul CK, Tan SE. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse (New York, N.Y.). 18: 205-17. PMID 7855733 DOI: 10.1002/syn.890180306  1
1994 Eckenstein FP, Kuzis K, Nishi R, Woodward WR, Meshul C, Sherman L, Ciment G. Cellular distribution, subcellular localization and possible functions of basic and acidic fibroblast growth factors. Biochemical Pharmacology. 47: 103-10. PMID 7508717 DOI: 10.1016/0006-2952(94)90442-1  1
1992 Woodward WR, Nishi R, Meshul CK, Williams TE, Coulombe M, Eckenstein FP. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 142-52. PMID 1729432  1
1992 Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology. 106: 45-52. PMID 1531388 DOI: 10.1007/BF02253587  1
1992 See RE, Chapman MA, Meshul CK. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse (New York, N.Y.). 12: 147-54. PMID 1362290 DOI: 10.1002/syn.890120208  1
1990 Meshul CK, Hopkins WF. Presynaptic ultrastructural correlates of long-term potentiation in the CA1 subfield of the hippocampus. Brain Research. 514: 310-9. PMID 2357543 DOI: 10.1016/0006-8993(90)91426-H  1
1990 Meshul CK, Kriho V, Kriho N, Hopkins WF, Matsumura F, Pappas GD. Calcium channel blocker influences the density of alpha-actinin labeling at the rat neuromuscular junction. Muscle & Nerve. 13: 348-54. PMID 2355947 DOI: 10.1002/mus.880130411  1
1989 Meshul CK. Calcium channel blocker reverses anticholinesterase-induced myopathy. Brain Research. 497: 142-8. PMID 2790449 DOI: 10.1016/0006-8993(89)90980-3  1
1989 Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Research. 489: 338-46. PMID 2568156 DOI: 10.1016/0006-8993(89)90867-6  1
1989 Woodward WR, Meshul CK, Coull BM. Ultrastructural and functional evidence for the survival of corticogeniculate neurons in kainic acid-lesioned lateral geniculate nucleus. Brain Research. 494: 42-54. PMID 2548672 DOI: 10.1016/0006-8993(89)90142-X  1
1985 Meshul CK, Boyne AF, Deshpande SS, Albuquerque EX. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles. Experimental Neurology. 89: 96-114. PMID 4007120 DOI: 10.1016/0014-4886(85)90268-7  1
1984 Meshul CK, Pappas GD. The relationship of pinocytosis and synaptic vesicles at the frog neuromuscular junction. Brain Research. 290: 1-18. PMID 6607088 DOI: 10.1016/0006-8993(84)90730-3  1
Show low-probability matches.